NIH Awards New England Biolabs Grant for the Research and Development of Novel Enzymes for Epigenetic Studies
Published: Friday, November 09, 2012 Last Updated: Friday, November 09, 2012
New England Biolabs (NEB) has recently received a $640,000 Phase II Small Business Innovation Research (SBIR) grant to expand its research and product development of novel enzymatic tools for epigenetic analysis.
Full access to this article is for registered users only. Registration is free-of-charge and allows access to all content on our web communities.
Already registered? Then please log in at the top of the page.